Biotech Stocks Today: MannKind Corporation (MNKD), Celgene Corporation (CELG), Zogenix (ZGNX), Novogen (NVGN)

MannKind Corporation Climbs As Short Interest Declines MannKind Corporation (NASDAQ: MNKD) MannKind Corporation stock is having a great day in the market today. When it comes to MNKD, one big concern for several investors is the high level of short interest. However, according to Dakota Financial News, MNKD short interest fell by more than 4% … Read more

Analysts Provide Insight on Celgene Corporation (CELG) And Receptos Inc (RCPT) in Light of Acquisition Announcement

By Cody Miecnikowski Oncology therapy company Celgene Corporation (NASDAQ:CELG) announced a definitive agreement on July 14 to acquire Receptos Inc (NASDAQ: RCPT). Under the terms of the agreement, Celgene will pay $7.2 billion in cash for the autoimmune drug maker. The boards of both companies have approved the terms of the acquisition and expect it … Read more

Biopharmaceutical Summer Highlights: Intercept Pharmaceuticals, Receptos, and XOMA

By Sarah Roden Last week, Liana Moussatos of Wedbush released a report highlighting a list of upcoming catalysts for biopharmaceutical companies. Specifically, she noted forthcoming events for Intercept Pharmaceuticals Inc (NASDAQ:ICPT), Receptos Inc (NASDAQ:RCPT), and XOMA Corp (NASDAQ:XOMA). Moussatos has a 51% success rate recommending stocks with a +32.6% average return per rating. Intercept Pharmaceuticals … Read more